Canada - English - Health Canada

amway canada corporation - avobenzone; octinoxate - cream - 3.0%; 7.5% - avobenzone 3.0%; octinoxate 7.5% - sunscreen agents

Canada - English - Health Canada

arbonne international llc - titanium dioxide; octinoxate - cream - 8.5%; 5.0% - titanium dioxide 8.5%; octinoxate 5.0% - sunscreen agents

Canada - English - Health Canada

arbonne international llc - octinoxate; titanium dioxide - cream - 6.0%; 3.2% - octinoxate 6.0%; titanium dioxide 3.2% - sunscreen agents

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; calcium carbonate; pregelatinised maize starch; gelatin; titanium dioxide; hypromellose; sunset yellow fcf; erythrosine; macrogol 400 - 1. angina pectoris. 2. hypertension. 3. prevention of migraine. 4. cardiac dysrythmias: certain intrinsic cardiac dysrythmias; dysrythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug induced dysrythmias (eg. tachycardia due to digitalis or adrenaline overdosage). 5. essential tremor including familial and senile tremor. 6. phaeochromocytoma (only with concurrent alpha antagonist). 7. hypertrophic subaortic stenosis. 8. suspected or definite myocardial infarction.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - propranolol hydrochloride, quantity: 160 mg - tablet, film coated - excipient ingredients: magnesium stearate; calcium carbonate; croscarmellose sodium; gelatin; pregelatinised maize starch; titanium dioxide; hypromellose; sunset yellow fcf; erythrosine; macrogol 400 - 1. angina pectoris. 2. hypertension. 3. prevention of migraine. 4. cardiac dysrythmias: certain intrinsic cardiac dysrythmias; dysrythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug induced dysrythmias (eg. tachycardia due to digitalis or adrenaline overdosage). 5. essential tremor including familial and senile tremor. 6. phaeochromocytoma (only with concurrent alpha antagonist). 7. hypertrophic subaortic stenosis. 8. suspected or definite myocardial infarction.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; croscarmellose sodium; calcium carbonate; magnesium stearate; gelatin; titanium dioxide; hypromellose; sunset yellow fcf; erythrosine; macrogol 400 - 1. angina pectoris. 2. hypertension. 3. prevention of migraine. 4. cardiac dysrythmias: certain intrinsic cardiac dysrythmias; dysrythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug induced dysrythmias (eg. tachycardia due to digitalis or adrenaline overdosage). 5. essential tremor including familial and senile tremor. 6. phaeochromocytoma (only with concurrent alpha antagonist). 7. hypertrophic subaortic stenosis. 8. suspected or definite myocardial infarction.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - auranofin, quantity: 3 mg - tablet, film coated - excipient ingredients: titanium dioxide; maize starch; lactose monohydrate; magnesium stearate; iron oxide yellow; microcrystalline cellulose; hypromellose; purified water; sodium starch glycollate; propylene glycol; ethanol - indications as at 14 november 2000: adjunctive treatment of active classical or definite rheumatoid arthritis in adults who have an insufficient therapeutic response to, or are intolerant of, an adequate trial of a baseline therapeutic program, including among other measures, full doses of one or more non-steroidal anti-inflammatory drugs. ridaura is not indicated in non-rheumatoid arthropathies such as osteoarthrosis. ridaura should be added to a comprehensive baseline therapeutic program.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - metoprolol tartrate, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate; povidone; magnesium stearate - indications as at 23 november 2004 : oral therapy - hypertension, angina pectoris prophylaxis, suspected or definite myocardial infarction, migraine prophylaxis.

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: carmellose calcium; magnesium stearate; carmine; lactose monohydrate; hypromellose; gelatin; titanium dioxide; glycerol - 1. angina pectoris, 2. hypertension, 3. prevention of migraine, 4. cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (e.g. tachycardia due to digitalis or adrenaline overdosage), 5. essential tremor, including familial and senile tremor, 6.phaeochromocytoma (only with concurrent alpha-receptor blockade), 7. hypertrophic subaortic stenosis, 8. suspected or definite myocardial infarction, 9. fallot's tetralogy.

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: carmellose calcium; carmine; magnesium stearate; gelatin; hypromellose; glycerol; titanium dioxide; lactose monohydrate - indications as at 05 mar 02 : 1. angina pectoris, 2. hypertension, 3. prevention of migraine, 4. cardiac dysrhythmias : certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (e.g. tachycardia due to digitalis or adrenaline overdosage), 5. essential tremor, including familial and senile tremor, 6.phaeochromocytoma (only with concurrent alpha-receptor blockade), 7. hypertrophic subaortic stenosis, 8. suspected or definite myocardial infarction, 9. fallot's tetralogy.